|
Maria C. Freire, Ph.D., is President of the Foundation for the National Institutes of Health, and is a member of the Advisory Committee to the Director of the National Institutes of Health.〔http://www.nih.gov/news/health/apr2009/od-03.htm〕 ==Career== Dr. Maria C. Freire was appointed President and Executive Director of Foundation for the National Institutes of Health (FNIH) on November 2012. The FNIH draws together the world’s foremost researchers and resources in support of the mission of the NIH. Prior to this appointment, Dr. Freire was the President of the Albert and Mary Lasker Foundation. From 2001 to 2008, she was the President and Chief Executive Officer of the Global Alliance for TB Drug Development.〔http://new.tballiance.org/newscenter/view-brief.php?id=684〕 Dr. Freire directed the Office of Technology Transfer at the National Institutes of Health from 1995 to 2001, where she oversaw the transfer of federally funded technology from the not-for-profit sector to the for-profit sector and ensured continuing availability of technology as to not limit basic research or encumber future products for public benefit.〔http://www.hhs.gov/asl/testify/t010801.html〕 Prior to that, Dr. Freire established and headed the Office of Technology Development at the University of Maryland, Baltimore and the University of Maryland, Baltimore County. Dr. Freire was made a member of the Council on Foreign Relations in 2009.〔http://www.cfr.org/content/about/annual_report/ar_2009/AR_2009_for_print.pdf〕 In 2008, Dr. Freire was elected to the Institute of Medicine.〔http://www.iom.edu/CMS/59070.aspx〕 She also served as a member of the Commission of Intellectual Property Rights, Innovation and Public Health of the World Health Organization and on the International Advisory Committee for the Instituto Carso de la Salud. 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Maria Freire」の詳細全文を読む スポンサード リンク
|